Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19
Pharmacology
[키워드] Admission
alanine aminotransferase
ALB
albumin
alleviate
ALT
Aspartate aminotransferase
AST
C-reactive protein
circulating cytokine
clinical
collected
Concentration
Continuous
Continuous renal replacement therapy
control group
coronavirus disease
COVID-19
Critical
CRP
CRRT
CRS
Cytokine release syndrome
Cytokine storm
demographic
determine
fibrinogen
Filter
hospital
Hospitalization
hyper inflammation
ICU
IFN-γ
IL-10
IL-2
IL-4
IL-6
individual
inflammatory chemokines
intervention group
IRB
lymphocyte
Lymphocyte count
medical records
medical system
neutrophil
no significant difference
non-acute kidney injury
Organ failure
oXiris filter
Patient
Platelet
proportion
Protein
random number table
randomly divided
Release
renal replacement therapy
replacement
Resolution
SARS-COV-2 infection
sensitivity
serum creatinine
severe and critical COVID-19
severity of COVID-19
significantly
significantly higher
significantly lower
SOFA
strained
TNF-α
total bilirubin
treated
Treatment
two groups
WBC
White blood cell
[DOI] 10.3389/fphar.2022.817793 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2022.817793 PMC 바로가기 [Article Type] Pharmacology